QUALITY ADJUSTED LIFE YEARS (QALYS) IN ECONOMIC EVALUATIONS OF HEALTH TECHNOLOGIES IN SPAIN- A REVIEW OF THE 2003-2009 LITERATURE

Author(s)

Lizan Tudela LV1, Paz S2, Rodriguez JM3, González P31Jaune I Unversity, Castellon de la Plana, Castellon, Spain, 2Outcomes'10 Research Group, Castellon, Castellon, Spain, 3Medtronic Iberia, Madrid, Spain

OBJECTIVES: To appraise economic evaluations of health technologies that included QALYs as an outcome measure conducted over the last seven years in Spain. METHODS: Economic evaluations that included QALYs as an outcome measure, conducted in Spain and published between January, 2003 and April, 2009 were identified. A combination of terms was applied to systematically review electronic and grey literature sources. Three Spanish journals were hand searched. Methodological quality was assessed applying the National Institute of Clinical Excellence (NICE) 10 criteria checklist and the Oxford Centre for Evidence Based Medicine (CEBM) recommendations for appraising economic evaluations. RESULTS: After applying the inclusion and exclusion criteria, a total of 48 papers and 1 Health Technologies Evaluation Agency (HTEAs) report were included. Key findings: 1) 69.5% of papers referred to therapeutic interventions; 30.4% to preventive strategies; 2) no assessments of diagnostic procedures were identified; 3)10.4% dealt with medical devices; 4) Markov modelling was frequently applied (58.7%); 5) the NHS perspective was commonly adopted (56.5%); 6) costs and effects were usually discounted (71.7%); 7) probabilistic methods were reported in 36.4% papers; 8) in 91.9%, either the ICER or ICUR was stated; 9) effectiveness, costs and utility data came from Spanish sources in 15.2% publications; 10) 60.8% of studies were of 3b level of evidence mainly due to the diverse nature of the sources consulted to gather data, estimate utilities and design models;11) 89% of authors compared their findings against an accepted threshold of €30,000 per QALY, but little attention was given to contrasting results or addressing other implementation issues; 12) 45.6% reported the source of funds. CONCLUSIONS: A small number of economic evaluations using QALYs was conducted. Diagnostic and preventive interventions as well as medical devices were scarcely considered. Low evidence scores show that important methodological limitations remain unsolved to produce reliable estimates to guide the allocation of resources.

Conference/Value in Health Info

2009-10, ISPOR Europe 2009, Paris, France

Value in Health, Vol. 12, No. 7 (October 2009)

Code

PHP64

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Health Care Research

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×